ロード中...
Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study
OBJECTIVE: To evaluate the relationship between number of metabolic syndrome (MetS)-like components and prostate cancer diagnosis in a group of men where nearly all biopsies were taken independent of prostate-specific antigen (PSA) level, thus minimising any confounding from how the various MetS-lik...
保存先:
| 出版年: | BJU Int |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4564864/ https://ncbi.nlm.nih.gov/pubmed/24931061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bju.12843 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|